| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |